The Journal of Clinical Investigation (Jan 2023)

Mitochondrial dysfunction reactivates α-fetoprotein expression that drives copper-dependent immunosuppression in mitochondrial disease models

  • Kimberly A. Jett,
  • Zakery N. Baker,
  • Amzad Hossain,
  • Aren Boulet,
  • Paul A. Cobine,
  • Sagnika Ghosh,
  • Philip Ng,
  • Orhan Yilmaz,
  • Kris Barreto,
  • John DeCoteau,
  • Karen Mochoruk,
  • George N. Ioannou,
  • Christopher Savard,
  • Sai Yuan,
  • Osama H.M.H. Abdalla,
  • Christopher Lowden,
  • Byung-Eun Kim,
  • Hai-Ying Mary Cheng,
  • Brendan J. Battersby,
  • Vishal M. Gohil,
  • Scot C. Leary

Journal volume & issue
Vol. 133, no. 1

Abstract

Read online

Signaling circuits crucial to systemic physiology are widespread, yet uncovering their molecular underpinnings remains a barrier to understanding the etiology of many metabolic disorders. Here, we identified a copper-linked signaling circuit activated by disruption of mitochondrial function in the murine liver or heart that resulted in atrophy of the spleen and thymus and caused a peripheral white blood cell deficiency. We demonstrated that the leukopenia was caused by α-fetoprotein, which required copper and the cell surface receptor CCR5 to promote white blood cell death. We further showed that α-fetoprotein expression was upregulated in several cell types upon inhibition of oxidative phosphorylation. Collectively, our data argue that α-fetoprotein may be secreted by bioenergetically stressed tissue to suppress the immune system, an effect that may explain the recurrent or chronic infections that are observed in a subset of mitochondrial diseases or in other disorders with secondary mitochondrial dysfunction.

Keywords